Principal Financial Group Inc Co Diagnostics, Inc. Transaction History

Principal Financial Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$3.76 - $6.29 $186,691 - $312,311	-49,652 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$5.03 - $9.61 $126,660 - $241,989	-25,181 Reduced 33.65%	49,652 $307,000
Q4 2021 Feb 09, 2022	SELL	$8.12 - $10.37 $531,015 - $678,156	-65,396 Reduced 46.64%	74,833 $668,000
Q3 2021 Nov 09, 2021	SELL	$7.48 - $11.38 $14,286 - $21,735	-1,910 Reduced 1.34%	140,229 $1.36 Million
Q2 2021 Aug 10, 2021	SELL	$7.16 - $9.56 $144,589 - $193,054	-20,194 Reduced 12.44%	142,139 $1.17 Million
Q1 2021 May 10, 2021	BUY	$8.52 - $19.21 $105,520 - $237,915	12,385 Added 8.26%	162,333 $1.55 Million
Q4 2020 Feb 08, 2021	BUY	$9.3 - $15.19 $1.39 Million - $2.28 Million	149,948 New	149,948 $1.4 Million

4.28M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $33.4M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.